(LifeSite). A recent analysis of documents obtained by freedom of information lawsuits reveal COVID “vaccine” manufacturers such as Pfizer, Moderna, and Janssen are only “figureheads” in the production of experimental injections that are actually produced, fully controlled and distributed by the U.S. Department of Defense (DOD).
Research conducted by retired pharmaceutical industry executive Alexandra Latypova discovered that “kind of like an iceberg” these biological products are “made by a consortium of companies” that are “traditional and nontraditional suppliers to the Department of Defense.”
In addition, “possession [of the product] is never taken by anybody other than [the] U.S. federal government,” she said, resulting in a situation where the methods of production and contents of these products “cannot be traced.”
Furthermore, not only are these biologicals produced in this “opaque black box,” but they remain the property of the U.S. government “until they are injected into the person,” which means any American who obtains the vials in order to study the contents can be prosecuted for “stealing government property” or the like. And it remains a contractual violation for governments outside the U.S. to test these products.
DOD ‘not a licensed pharmacy distributor,’ and thus do not ‘need to comply with any laws’
Additionally, since the organizational structure of the project explicitly names the DOD as “the chief operating officer of the entire enterprise” and they are “not a licensed pharmacy distributor,” Latypova said “they don’t need to comply with any laws” that govern that industry.
Therefore, though these products are not “vaccines,” or, according to Latypova, even medicines, the public naturally has presumed standard industry safeguards for such products to be in place, when this has not been the case.
For example, the distribution of these products “is not going through the licensed pharmacy distributors who are bound by a set of regulations called ‘good distribution practices,’” the scientist said.
Hence, though hospitals do not know, or can they verify, the contents or manufacturing process of these products, they just “essentially get the black box shipment and then they are supposed to inject it into people. As a doctor, you understand how illegal this is,” she told McCullough.
Severe variability in serious adverse reactions among batches points to grave violation of the law
The consortium of companies utilized by the DOD that manufacture such products include hundreds of names such as National Resilience, Snapdragon, Patheon, Becton, Dickinson, Corning, Grand River, Sio2, Texas A&M University, and many other universities, Latypova said.
It also includes Emergent Biosolutions that was the DOD’s “exclusive manufacturer of anthrax vaccine,” which also faced enormous safety issues, though it was “not forced on every person on the globe … [but just] our armed forces for a while,” she said.
In addition, the former executive identified Catalent as “another manufacturer that’s a supplier to Moderna,” which was recently found to be in violation of good manufacturing practices (GMP) requirements by the FDA.
Latypova, who worked for 20 years co-founding and managing companies that served the fields of clinical trials, data collection and analysis, told LifeSite in January that GMP laws are “designed to ensure safety and consistency of pharmaceutical products which must be produced in large quantities to very exacting standards of purity, stability, consistency, etc.”
“Breaches of these practices have historically resulted in tragic cases of adulterated, tainted, or poisoned drug products which resulted in loss of life and severe injuries,” she wrote in an email correspondence at the time.
According to an earlier presentation, she showed how GMP laws include expectations that every new lot/batch [of a product] is “almost the same” as all previous lots, and that vaccines from different manufacturers “for a disease indication are ‘the same’ or interchangeable product.”
Quoting the specific regulation, Latypova said, “‘The failure to comply (with these practices) … shall render such drug to be adulterated,’ and that is a pretty significant crime to sell adulterated products.”
Given the enormous variability from most batches of these experimental COVID injections (70% to 80%), which had shown just one or two reported serious adverse reactions as compared to 4% to 5% that revealed thousands, “severe non-compliance” with GMP standards is clearly indicated “and must be investigated,” Latypova concluded.
FDA conflict of interest, designs and approves product, inspections are ‘theater’
As the DOD is the chief operating officer of the project, recent documents also show the Food and Drug Administration (FDA) is identified as the chief science officer of the enterprise. “So, FDA, in fact, is responsible for design, development, clinical trials and approval of this product,” Latypova reported, emphasizing the clear potential conflict of interest.
For example, while the FDA performed no inspections of these manufacturers in 2020 (due to supposed COVID restrictions) their recent finding of Catalent being, as Latypova describes, “completely non-GMP-compliant,” including “a bunch of observations that are just awful and normally would result in the shutdown of a facility until they can be resolved,” there was no enforcement from the FDA and “manufacturing continues as before.”
Emergent Biosolutions has also been identified as noncompliant, which means, according to the former executive, “the entire chain [of production] is not [compliant].” Such inspections seem to be “theater, essentially,” she said. “The inspector will write up observations, but nothing happens. There’s no enforcement whatsoever,” and these DOD contractors were permitted to simply continue their production.
Yet there has been just one exception to this that happened abroad where upon inspection Japanese regulators reportedly found “metal, steel, a stainless steel and flakes” contained in the injection substance and returned these contaminated lots back to Moderna, she reported. But this is the only example Latypova is aware of where a regulator did anything about these issues.
Metallic structures discovered in Pfizer vax ‘seem to respond to electromagnetic fields’
While American individuals may be liable to indictment for examining the substance of these vials, whether or how this regulation applies to those in foreign nations is unclear.
Thus, Dr. David Nixon, an Australian general practitioner from Brisbane, decided to take a closer look at the Pfizer product to see what he might discover about its contents.
As reported by the Spectator, the physician put “droplets of vaccine and the blood of vaccinated patients under a dark-field microscope” and filmed what was there. According to Rebecca Weisser of the outlet, the discovery “is bizarre to say the least.”
“Inside a droplet of vaccine are strange mechanical structures. They seem motionless at first but when Nixon used time-lapse photography to condense 48 hours of footage into two minutes, it showed what appear to be mechanical arms assembling and disassembling glowing rectangular structures that look like circuitry and microchips,” Weisser wrote.
Asked if she might be familiar with this phenomenon, Latypova told LifeSiteNews in a November 17 email correspondence that she knows Nixon and has spoken to him several times.
His discovery of “inexplicable structures in the Pfizer vax” is not unique, she said, and has been observed by others as well. “It warrants investigation.”
“I cannot say what these things are, just that we know size alone is problematic since these are observable under standard optical microscope, so these are very large structures. They form pretty quickly and they also seem to respond to electromagnetic fields, such as a WIFI router in the office,” she wrote.
“This is not something declared on the product label and so this needs to be explained by the manufacturer who we know is not eager to explain anything about their product and are very eager to inject everyone without informed consent,” she concluded.
Sharp spikes in death resulting from COVID gene-based vaccines corroborated by many sources
For example, last January, Scott Davison, the president of OneAmerica insurance in Indianapolis, called attention to the industry’s 40% increase in 2021 third-quarter death rates, which were the highest the company has “seen in the history of the business.”
“Just to give you an idea of how bad that is, a three-sigma or a one-in-200-year catastrophe would be 10% increase over pre-pandemic,” he said. “So, 40% is just unheard of.”
Soon after this revelation, former entrepreneur-turned-journalist Steve Kirsch crunched the numbers and provided an extensive argument for why these excess non-COVID-related deaths were most likely caused by the COVID vaccines. The MIT graduate explained such a catastrophe would only happen by pure chance every 2.8e32 years, which is “basically never.”
“In other words, the event that happened [to bring this about] is not a statistical ‘fluke.’ Something caused a very big change,” he said.
The significant increases in deaths are also corroborated by a January 2022 reportissued by the Society of Actuaries Research Institute (SOA) showing excess life insurance death claims spiked 37.7% in the third quarter of 2021 over a pre-pandemic baseline (2017-2019). That figure included an approximate 50-50 split between claims related to COVID-19 and those caused by other factors.
In addition, Andreas Schöfbeck, a board member of German health insurer BKK ProVita, issued a letter in February that he sent to government authorities indicating “a very considerable under-recording of suspected cases of vaccination side effects after [patients] received the [COVID-19] vaccine.”
According to his company’s internal data, around 4%-5% of the vaccinated were under medical treatment for side effects,” he wrote, a rate about 10 times higher than the German government had been reporting.
Furthermore, in June, records obtained from the Michigan Department of Insurance and Financial Services showed that Lincoln National Life Insurance Company paid out 163% more in death benefits for working clients ages 18 to 64 in 2021 over the previous pandemic year of 2020.
In the United States, while the Centers for Disease Control’s passive Vaccine Adverse Event Reporting System (VAERS) received only around 150 annual death reports before 2021, it currently shows 1,458,322 reports of adverse events after COVID vaccines administered between Dec. 14, 2020, and November 4, 2022. This data includes a total 31,961 reports of deaths, 182,907 hospitalizations, and 59,831 permanent disabilities.
And like the findings of BKK ProVita, there’s plenty of evidence that this is just the “tip of the iceberg” considering a 2010 Harvard-executed study commissioned by the Department of Health and Human Services (HHS) found that “fewer than 1% of vaccine adverse events are reported” in VAERS.
Another study commissioned by vaccine manufacturer Connaught Laboratories calculated a “fifty-fold underreporting of adverse events” is likely.
With experimental COVID-19 gene-based vaccine campaigns being largely implemented in 2021, including the extensive employer and educational mandates being imposed upon the population, U.S. military personnel and their families have reportedly experienced spike increases over a five-year baseline in neurological diseases (1,048% increase), high blood pressure (2,281%), heart attacks (at least 269%), pulmonary blood clots (467%), and cancer (296%).
